Form 4 for CNMD CONMED Corp
Accepted 2022-05-12 00:00:00 ET · period of report 2022-05-10 · accession 0001127602-22-014261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-12 | 2022-05-10 | CNMD | Peterson Jaclyn | VP of Mfg, Adv. Engineering | M - OptEx | $0.00 | +500 | 733 | +215% | $0 |
| D | 2022-05-12 | 2022-05-10 | CNMD | Peterson Jaclyn | VP of Mfg, Adv. Engineering | F - Tax | $109.31 | -154 | 579 | -21% | -$16.8K |
| D | 2022-05-12 | 2022-05-10 | CNMD | Peterson Jaclyn | VP of Mfg, Adv. Engineering | M - OptEx | $0.00 | -500 | 1,500 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-10 | M | A | 500 | $0.00 | 733 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-10 | F | D | 154 | $109.31 | 579 | D | — | — | |
| 3 | Derivative | Rsus (restricted Stock Units) | 2022-05-10 | M | D | 500 | $0.00 | 1,500 | D | $0.00 · — to 2031-05-10 | 500 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |